Diabetes Type 2
Designed to evaluate the effectiveness of a new oral medication in controlling blood sugar levels in adults with Type 2 Diabetes who are already taking Metformin.
Qualification Requirements
- Men and Women
- Ages 18-75
- generally good health
- Diagnosed with Type 2 Diabetes
- Currently taking Metformin
- Non-smoker or former smoker
- Not currently using insulin
COMPENSATION: $3,000
Study Details
Designed to evaluate the effectiveness of a new oral medication in controlling blood sugar levels in adults with Type 2 Diabetes who are already taking Metformin. This study will consist of 17 outpatient visits, and 3 safety phone calls and has a duration of 4 months.
Designed to evaluate the effectiveness of a new oral medication in controlling blood sugar levels in adults with Type 2 Diabetes who are already taking Metformin. This study will consist of 17 outpatient visits, and 3 safety phone calls and has a duration of 4 months.